Search

Drozitumab

It was developed by Genentech as a drug for the treatment of cancers

5-deoxyflavanone

These are compounds containing a flavan-3-one moiety, whose structure is characterized by a 2-phenyl-3,4-dihydro-2H-1-benzopyran bearing a ketone at the carbon C3.

Prostaglandin D2

It is released upon activation of mast cells and is also synthesized by alveolar macrophages.

SB-269970

SB-269970 is an experimental drug developed by GlaxoSmithKline.

Irampanel

Irampanel is under investigation in clinical trial NCT02222961 (Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers).

Aftobetin

Aftobetin is under investigation in clinical trial NCT02928211 (Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations).

Sodium phosphate, monobasic, unspecified form

Rilpivirine

[A31331] Rilpivirine was developed by Tilbotec, Inc. and FDA approved on May 20, 2011.

Daraxonrasib

[L64040,L64041] It is taken by mouth once daily.

Trimethaphan

A nicotinic antagonist that has been used as a ganglionic blocker in hypertension, as an adjunct to anesthesia, and to induce hypotension during surgery.